UB 612
Alternative Names: COVID-19 vaccine - COVAXX; MPV - COVAXX; Multitope COVID-19 Vaccine - COVAXX; Multitope peptide based vaccine - COVAXX; UB-612Latest Information Update: 28 Aug 2024
At a glance
- Originator COVAXX
- Developer COVAXX; United Biomedical
- Class COVID-19 vaccines; Peptide vaccines; Synthetic vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preregistration COVID 2019 infections
Most Recent Events
- 28 Aug 2024 No recent reports of development identified for preclinical development in COVID-2019-infections(Prevention) in USA (Parenteral)
- 09 Aug 2023 MHRA accepts conditional/provisional marketing authorization application for UB 612 for COVID-2019 infections for review
- 09 Aug 2023 TGA accepts conditional/provisional marketing authorization application for UB 612 for COVID-2019 infections for review